The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of higher total nucleated cell dose with improved survival in patients receiving donor lymphocyte infusion after allogeneic stem cell transplantation.
 
Nathan Singh
No Relationships to Disclose
 
Anita J. Kumar
No Relationships to Disclose
 
Amy Gao
No Relationships to Disclose
 
Marlise Rachael Luskin
No Relationships to Disclose
 
Noelle V. Frey
No Relationships to Disclose
 
Elizabeth O. Hexner
No Relationships to Disclose
 
Alison W. Loren
No Relationships to Disclose
 
Selina M. Luger
No Relationships to Disclose
 
Edward Allen Stadtmauer
No Relationships to Disclose
 
David L. Porter
Employment - Genentech/Roche (I)
Stock and Other Ownership Interests - Celgene
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - Patent/royalty rights
 
Ran Reshef
Consulting or Advisory Role - Celgene; Spectrum Pharmaceuticals; Teva
Research Funding - Pfizer (Inst); Tobira Therapeutics (Inst)